← Insider buys
GKOS

Glaukos Corporation · Healthcare

Chief Development Officer Tomas Navratil sold $100K of Glaukos Corporation

Sold$99,567
$139.06Price
716Shares
−1%Stake

What GKOS did after the filing

Filed Jul 9, copier in the same day
The stock from Thu, Jul 9 open, $153.29
+20.6%
S&P 500, same days
+2.5%

Measured over 30 trading days, to the Aug 21 close.

Traded Wed, Jul 1. Filed Wed, Jul 8, 8:53 PM ET, after the close. Returns use the Jul 9 open and the Aug 21 close. Not investment advice.